Nanotechnologies to Improve the Pharmacological Profile of Therapeutic Peptides

Author(s): Bruno Casciaro, Maria Luisa Mangoni.

Journal Name: Current Protein & Peptide Science

Volume 21 , Issue 4 , 2020

Become EABM
Become Reviewer

[1]
Pitts, P.J.; Louet, H.L.; Moride, Y.; Conti, R.M. 21st century pharmacovigilance: efforts, roles, and responsibilities. Lancet Oncol., 2016, 17(11), e486-e492.
[2]
Hughes, D.; Andersson, D.I. Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat. Rev. Genet., 2015, 16(8), 459-471.
[3]
Xu, Q.; Kambhampati, S.P.; Kannan, R.M. Nanotechnology approaches for ocular drug delivery. Middle East Afr. J. Ophthalmol., 2013, 20(1), 26-37.
[4]
Casciaro, B.; Cappiello, F.; Cacciafesta, M.; Mangoni, M.L. Promising approaches to optimize the biological properties of the antimicrobial peptide esculentin-1a(1-21)NH2: Amino Acids Substitution and Conjugation to Nanoparticles. Front. Chem., 2017, 5, 26.
[5]
Hassanzadeh, P.; Atyabi, F.; Dinarvand, R. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders. Life Sci., 2017, 182, 93-103.
[6]
Yang, Z.; Ma, Y.; Zhao, H.; Yuan, Y.; Kim, B.Y.S. Nanotechnology platforms for cancer immunotherapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2020, 12(2), e1590
[7]
Lau, J.L.; Dunn, M.K. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg. Med. Chem., 2018, 26(10), 2700-2707.
[8]
Wang, J.; Wu, J.; Li, Y.; Wen, J.; Cai, J.; Tang, T.; Hu, X.; Xiang, D. The brief analysis of peptide-combined nanoparticle: nanomedicine’s unique value. Curr. Protein Pept. Sci., 2020, 21(4), 334-343.
[9]
Santoni, M.; Zampieri, R.; Avesani, L. Plant virus nanoparticles for vaccine applications. Curr. Protein Pept. Sci., 2020, 21(4), 344-356.
[10]
Willcox, M.D.P.; Chen, R.; Kalaiselvan, P.; Yasir, R.; Rasul, L.; Kumar, N.; Dutta, D. The development of an antimicrobial contact lens – from the laboratory to the clinic. Curr. Protein Pept. Sci., 2020, 21(4), 357-368.
[11]
Adlakha, S.; Sharma, A.; Vaghasiya, K.; Ray, E.; Verma, R.K. Inhalation delivery of host defense peptides (HDP) using nano-formulation strategies: A pragmatic approach for therapy of pulmonary ailments. Curr. Protein Pept. Sci., 2020, 21(4), 369-378.
[12]
Covarrubias-Zambrano, O.; Yu, J.; Bossmann, S.H. Nano-inspired technologies for peptide delivery. Curr. Protein Pept. Sci., 2020, 21(4), 379-400.
[13]
Pentlavalli, S.; Coulter, S.; Laverty, G. Peptide nanomaterials for drug delivery applications. Curr. Protein Pept. Sci., 2020, 21(4), 401-412.
[14]
Mohid, Sk. A.; Bhunia, A. Combining antimicrobial peptides with nanotechnology: an emerging field in theranostics. Curr. Protein Pept. Sci., 2020, 21(4), 413-428.
[15]
Casciaro, B.; Ghirga, F.; Quaglio, D.; Mangoni, M.L. Inorganic gold and polymeric poly(lactide-co-glycolide) nanoparticles as novel strategies to ameliorate the biological properties of antimicrobial peptides. Curr. Protein Pept. Sci., 2020, 21(4), 429-438.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 4
Year: 2020
Page: [332 - 333]
Pages: 2
DOI: 10.2174/138920372104200320110232

Article Metrics

PDF: 13
HTML: 6
EPUB: 1
PRC: 1